Arterial Calcifications in Nocturnal Hemodialysis and Renal Transplantation Versus Conventional Dialysis
NCT ID: NCT00950573
Last Updated: 2018-12-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
184 participants
OBSERVATIONAL
2010-01-31
2018-12-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. To assess whether nocturnal hemodialysis and renal transplantation are associated with less progression of coronary arterial calcification, compared with conventional hemodialysis and peritoneal dialysis;
2. To identify the risk factors for coronary arterial calcification in dialysis and transplant patients, and to assess a possible interaction with treatment modality.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
hemodialysis
patients treated with conventional hemodialysis
No interventions assigned to this group
peritoneal dialysis
patients treated with peritoneal dialysis
No interventions assigned to this group
nocturnal hemodialysis
patients treated with frequent nocturnal hemodialysis
No interventions assigned to this group
kidney transplantation
patients treated with renal transplantation
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* current age \> 18 and \< 75 yr
* ability to understand the study procedures
* willingness to provide written informed consent
Exclusion Criteria
* claustrophobia
* allergy to iodinated contrast
* treatment incompliance, i.e. non-adherence to dialysis regimens and drug use
* GFR \< 30 ml/min (according to MDRD formula) in renal transplant patients
* pregnancy
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dianet Dialysis Centers
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Brigit van Jaarsveld, MD, PHD
Role: PRINCIPAL_INVESTIGATOR
Amsterdam UMC, location VUmc
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dianet Dialysis Centers
Utrecht, , Netherlands
University Medical Center Utrecht
Utrecht, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NOCTX
Identifier Type: -
Identifier Source: org_study_id